Integrating Services Across the Full Spectrum of Cell and Gene Therapy

Feb 11, 2022PAO-02-22-R250-10

On the Road to 50 States, Jennifer Chadwick, Vice President of Analytical Development at BioAnalytix (now ProtaGene), talks to Nigel about how the merger of the companies allows them to perform an integrated service function across the full spectrum of what’s needed for gene and cell therapy development.